🇺🇸 FDA
Patent

US 6949544

Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

expired A61PA61P1/04A61P11/00

Quick answer

US patent 6949544 (Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P1/04, A61P11/00, A61P11/06, A61P17/00